Effect of inter-renal aortic coarctation-induced hypertension on function and expression of vascular α1A- and α1D-adrenoceptors

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 1, 2012, Pages 1-12

  López Islas, Inés ^a   López Sánchez, Pedro ^b   Ibarra, Maximiliano ^c   Gallardo Ortiz, Itzell A ^c   Terrón, José A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Angiotensin ii; Aortic coarctation induced hypertension; Rats; Vascular 1D adrenoceptors

Indexed keywords

(5 METHYL 3 [3 [3 [4 [2 (2,2,2, TRIFLUROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 2,4 (1H,3H) PYRIMIDINEDIONE HYDROCHLORIDE; 5 METHYL 3 [3 [4 [2 (2,2,2 TRIFLUOROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 1H PYRIMIDINE 2,4 DIONE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ANGIOTENSIN II; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NORADRENALIN; UNCLASSIFIED DRUG;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA COARCTATION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SHAM PROCEDURE;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANGIOTENSIN II; ANIMALS; AORTA; AORTIC COARCTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION, RENOVASCULAR; IMIDAZOLES; MALE; NOREPINEPHRINE; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; TETRAHYDRONAPHTHALENES; THYMINE;

EID: 84855602670     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-099     Document Type: Article

References (49)

1. Arévalo-León, L.E., Gallardo-Ortíz, I.A., Urquiza-Marín, H., and Villalobos-Molina, R. 2003. Evidence for the role of α1D- and a1A-adrenoceptors in contraction of the rat mesenteric artery. Vascul. Pharmacol. 40(2): 91-96. doi:10.1016/S1537-1891(02)00336-1.
2. Badyal, D.K, Lata, H., and Dadhich, A.P. 2003. Animal models of hypertension and effect of drugs. Indian J. Pharmacol. 35(6): 349-362.
3. Bergström, G., Johansson, I., Wickman, A., Gan, L., and Thorup, C. 2002. Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure. J. Hypertens. 20(7): 1413-1421. doi:10.1097/00004872-200207000-00029.
4. Chen, D.G., Jin, X.Q., Wang, H.J., and Chen, S.C. 1995. Mechanisms responsible for sustained hypotension after captopril treatment. J. Hypertens. 13(10): 1113-1121. doi:10.1097/00004872-199510000-00006.
5. Conley, R.K., Williams, T.J., Ford, A.P., and Ramage, A.G. 2001. The role of alpha(1)-adrenoceptors and 5-HT(1A) receptors in the control of the micturition reflex in male anaesthetized rats. Br. J. Pharmacol. 133(1): 61-72. doi:10.1038/sj.bjp.0704043.
6. García-Sáinz, J.A., Vázquez-Cuevas, F.G., and Romero-Ávila, M.T. 2001. Phosphorylation and desensitization of α1d-adrenergic receptors. Biochem. J. 353(3): 603-610. doi:10.1042/0264-6021:3530603.
7. Gisbert, R., Noguera, M.A., Ivorra, M.D., and D'Ocon, P. 2000. Functional evidence of a constitutively active population of alpha (1D)-adrenoceptors in rat aorta. J. Pharmacol. Exp. Ther. 295(2): 810-817.
8. Gisbert, R., Ziani, K., Miquel, R., Noguera, M.A., Ivorra, M.D., Anselmi, E., and D'Ocon, P. 2002. Pathological role of a constitutively active population of α(1D)-adrenoceptors in arteries of spontaneously hypertensive rats. Br. J. Pharmacol. 135(1): 206-216. doi:10.1038/sj.bjp.0704447.
9. Godínez-Hernández, D., Gallardo-Ortíz, I.A., López-Sánchez, P., and Villalobos-Molina, R. 2006. Captopril therapy decreases both expression and function of alpha-adrenoceptors in pre-hypertensive rat aorta. Auton. Autacoid Pharmacol. 26(1): 21-29. doi:10.1111/j.1474-8673.2005.00358.x.
10. Guimarães, S., and Moura, D. 2001. Vascular adrenoceptors: an update. Pharmacol. Rev. 53(2): 319-356.
11. Harrap, S.B., Van der Merwe, W.M., Griffin, S.A., Macpherson, F., and Lever, A.F. 1990. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension, 16(6): 603-614.
12. Henrich, W.L., and Levi, M. 1991. Ontogeny of renal renin release in spontaneously hypertensive rat and Wistar-Kyoto rat. Am. J. Physiol. 260(4): F530-F535.
13. Horie, K., Obika, K., Foglar, R., and Tsujimoto, G. 1995. Selectivity of the imidazoline a-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned α 1-adrenoceptor subtypes. Br. J. Pharmacol. 116(1): 1611-1618.
14. Hu, Z.W., Shi, X.Y., Okazaki, M., and Hoffman, B.B. 1995. Angiotensin II induces transcription and expression of alpha 1- adrenergic receptors in vascular smooth muscle cells. Am. J. Physiol. 268(3): H1006-H1014.
15. Ibarra, M., Terron, J.A., Lopez-Guerrero, J.J., and Villalobos-Molina, R. 1997. Evidence for an age-dependent functional expression of α 1D-adrenoceptors in the rat vasculature. Eur. J. Pharmacol. 322(2-3): 221-224. doi:10.1016/S0014-2999(97)00092-7.
16. Ibarra, M., Pardo, J.P., Lopez-Guerrero, J.J., and Villalobos-Molina, R. 2000. Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and α 1A-adrenoceptors in contraction. Br. J. Pharmacol. 129(4): 653-660. doi:10.1038/sj.bjp.0703097.
17. Knepper, S.M., Buckner, S.A., Brune, M.E., DeBernardis, J.F., Meyer, M.D., and Hancock, A.A. 1995. A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the α 1A receptor subtype. J. Pharmacol. Exp. Ther. 274(1): 97-103.
18. Li, H.T., Long, C.S., Gray, M.O., Rokosh, D.G., Honbo, N.Y., and Karliner, J.S. 1997. Cross talk between angiotensin AT1 and alpha 1-adrenergic receptors: angiotensin II downregulates alpha 1aadrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ. Res. 81(3): 396-403.
19. López-Islas, I. L.-S. P., Ibarra-Barajas M, Gallardo-Ortíz IA, Terrón-Sierra JA. 2008. Effect of renovascular hypertension on function and expression of α-1 adrenoceptor subtypes in rats. Paper presented at the 2008 Neuroscience Meeting Planner, Washington, DC.
20. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J.1951. Protein measurement with the Folin's phenol reagent. J. Biol. Chem.193: 265-275.
21. Martínez-Salas, S.G., Campos-Peralta, J.M., Pares-Hipolito, J., Gallardo-Ortíz, I.A., Ibarra, M., and Villalobos-Molina, R. 2007. Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed. Auton. Autacoid Pharmacol. 27(3): 137-142. doi:10.1111/j.1474-8673.2007.00403.x.
22. Mendez, E., Calzada, C., Ocharan, E., Sierra, A., Castillo, C., Ramirez, I., et al. 2006. Differential expression of α1-adrenergic receptor subtypes in coronary microvascular endothelial cells in culture. Eur. J. Pharmacol. 546(1-3): 127-133. doi:10.1016/j.ejphar.2006.06.070.
23. Morton, J.J., Beattie, E.C., and MacPherson, F. 1992. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J. Vasc. Res. 29(3): 264-269. doi:10.1159/000158941.
24. Oliver, E., Marti, D., Monto, F., Flacco, N., Moreno, L., Barettino, D., et al. 2009. The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension. J. Pharmacol. Exp. Ther. 328(3): 982-990. doi:10.1124/jpet.108.146043.
25. Parés-Hipólito, J., Gómez-Zamudio, J.H., Gallardo-Ortiz, I.A., López-Guerrero, J.J., Santamaría-Ortiz, J., Ibarra, M., and Villalobos-Molina, R. 2006. Selective agonists reveal α(1A)- and α(1B)-adrenoceptor subtypes in caudal artery of the young rat. Auton. Autacoid Pharmacol. 26(4): 371-378. doi:10.1111/j.1474-8673.2006.00380.x.
26. Paull, J.R., and Widdop, R.E. 2001. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. J. Hypertens. 19 (8): 1393-1402. doi:10.1097/00004872-200108000-00007.
27. Piascik, M.T., Smith, M.S., Soltis, E.E., and Perez, D.M. 1994. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle. Mol. Pharmacol. 46(1): 30-40.
28. Piascik, M.T., Guarino, R.D., Smith, M.S., Soltis, E.E., Saussy, D.L., Jr, and Perez, D.M. 1995. The specific contribution of the novel α- 1D adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 275(3): 1583-1589.
29. Piascik, M.T., Hrometz, S.L., Edelmann, S.E., Guarino, R.D., Hadley, R.W., and Brown, R.D. 1997. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J. Pharmacol. Exp. Ther. 283(2): 854-868.
30. Pickering, T.G. L. J. 1991. Renovascular hypertension. In The kidney. Edited by R.F. Brenner BM, Jr. WB Saunders Co., Philadelphia, Pennsylvania. pp. 1940-1967.
31. Ruiz, P., Basso, N., Cannata, M.A., and Taquini, A.C. 1990. The renin-angiotensin system in different stages of spontaneous hypertension in the rat (SHR). Clin. Exp. Hypertens. 12(1): 63-81. doi:10.3109/10641969009074720.
32. Salomonsson, M., Brannstrom, K., and Arendshorst, W.J. 2000. α(1)- adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am. J. Physiol. Renal Physiol. 278(1): F138-F147.
33. Schiffrin, E.L., Thome, F.S., and Genest, J. 1984. Vascular angiotensin II receptors in SHR. Hypertension, 6(5): 682-688.
34. Scofield, M.A., Liu, F., Abel, P.W., and Jeffries, W.B. 1995. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 275(2): 1035-1042.
35. Tanoue, A., Nasa, Y., Koshimizu, T., Shinoura, H., Oshikawa, S., Kawai, T., et al. 2002. The α(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J. Clin. Invest. 109(6): 765-775.
36. Villalobos-Molina, R., and Ibarra, M. 1996. Alpha 1-adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the alpha 1D or alpha 1A subtypes. Eur. J. Pharmacol. 298(3): 257-263. doi:10.1016/0014-2999(95)00781-4.
37. Villalobos-Molina, R., and Ibarra, M. 2005. Increased expression and function of vascular a1D-adrenoceptors may mediate the prohypertensive effects of angiotensin II. Mol. Interv. 5(6): 340-342. doi:10.1124/mi.5.6.6.
38. Villalobos-Molina, R., Lopez-Guerrero, J.J., and Ibarra, M. 1997. Alpha 1D- and alpha 1A-adrenoceptors mediate contraction in rat renal artery. Eur. J. Pharmacol. 322(2-3): 225-227. doi:10.1016/S0014-2999(97)00095-2.
39. Villalobos-Molina, R., Lopez-Guerrero, J.J., and Ibarra, M. 1999. Functional evidence of α1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats. Br. J. Pharmacol. 126(7): 1534-1536. doi:10.1038/sj.bjp.0702468.
40. Villalobos-Molina, R., Vazquez-Cuevas, F.G., Lopez-Guerrero, J.J., Figueroa-Garcia, M.C., Gallardo-Ortiz, I.A., Ibarra, M., et al. 2008. Vascular alpha-1D-adrenoceptors are overexpressed in aorta of the aryl hydrocarbon receptor null mouse: role of increased angiotensin II. Auton. Autacoid Pharmacol. 28(2-3): 61-67. doi:10.1111/j.1474-8673.2008.00418.x.
41. Weir, M.R., and Dzau, V.J. 1999. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am. J. Hypertens. 12(12): 205S-213S. doi:10.1016/S0895-7061(99) 00103-X.
42. Welch, W.J., Patel, K., Modlinger, P., Mendonca, M., Kawada, N., Dennehy, K., et al. 2007. Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. Am. J. Physiol. Heart Circ. Physiol. 293(5): H2644-H2649. doi:10.1152/ajpheart.00748.2007.
43. Wilcox, C.S., Cardozo, J., and Welch, W.J. 1996. AT1 and TxA2/ PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat. Am. J. Physiol. 271(4): R891-R896.
44. Williams, T.J., Blue, D.R., Daniels, D.V., Davis, B., Elworthy, T., Gever, J.R., et al. 1999. In vitro a1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel a1A-adrenoceptor selective antagonists. Br. J. Pharmacol. 127(1): 252-258. doi:10.1038/sj.bjp.0702541.
45. Xin, X., Yang, N., Eckhart, A.D., and Faber, J.E. 1997. Alpha1Dadrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol. Pharmacol. 51(5): 764-775.
46. Ye, J.M., and Colquhoun, E.Q. 1998. Changes in functional expression of α-1 adrenoceptors in hindlimb vascular bed of spontaneously hypertensive rats and their effects on oxygen consumption. J. Pharmacol. Exp. Ther. 286(2): 599-606.
47. Zacharia, J., Hillier, C., and MacDonald, A. 2004. Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries. Br. J. Pharmacol. 141(6): 915-924. doi:10.1038/sj.bjp.0705690.
48. Zhou, L., and Vargas, H.M. 1996. Vascular α 1D-adrenoceptors have a role in the pressor response to phenylephrine in the pithed rat. Eur. J. Pharmacol. 305(1-3): 173-176. doi:10.1016/0014-2999(96)00229-4.
49. Zicha, J., and Kunes, J. 1999. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol. Rev. 79(4): 1227-1282.